Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium.

Source:http://linkedlifedata.com/resource/pubmed/id/12096002

Download in:

View as

General Info

PMID
12096002